Topics

Articles

Why ‘real-time-all-the-time’ supply chain operations are fundamental to         biopharma success

From Point-in-time to Real-time

The packaging and shipping of dangerous goods (DG) adds further challenges 
to the distribution pressures brought about by the pandemic

Dealing with Dangerous Goods

The clock is ticking on a massive effort to bring interoperable, electronic tracking of pharma shipments in the US

Countdown to 2023 DSCSA Compliance

A recommended checklist for manufacturers as they enlist distributor and 3PL support—and the important questions they should be asking themselves  

The Key Steps Ahead of DSCSA D-Day

Pressure is mounting ahead of looming unit-level serialization required by the Drug Supply Chain Security Act—necessitating a wide scope of collaboration on compliance

New Serialization Mandates Inch Closer

Outlining the work of the Open Credentialing Initiative in establishing digital proof of identity, licensure status, and authorship using digital wallets and verifiable credentials

Closing a Key Gap in DSCSA Compliance

The crucial link of labeling and packaging in the pharma supply chain has its glory, but is not without its set of obstacles amid current market and global challenges

Navigating Uneven Terrain in Labeling

Omar Agado, Vice President of 3PL Business Strategy & Services at 

What makes a third-party logistics provider independent?

Why Independent 3PLs Matter

Postponement, or late-stage customization, is an important approach for pharmaceutical manufacturers. Lee Feander provides an overview to help leaders assess its potential for higher performing supply chains.

Postponement: The Vital Supply Chain Strategy for Pharmaceutical Manufacturers

Having recently led the launch of LogiCare3PL, Omar Agado of BioCare talks about what’s next for the growing third-party logistics space

Supply Chain Logistics